{
    "id": "dbpedia_1128_2",
    "rank": 51,
    "data": {
        "url": "https://www.uab.edu/reporter/clinicaltrials",
        "read_more_link": "",
        "language": "en",
        "title": "The Reporter",
        "top_image": "https://www.uab.edu/styles/5.0/images/favicons/favicon-196x196.png",
        "meta_img": "https://www.uab.edu/styles/5.0/images/favicons/favicon-196x196.png",
        "images": [],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "/styles/5.0/images/favicons/favicon.ico",
        "meta_site_name": "",
        "canonical_link": "https://www.uab.edu/reporter/clinicaltrials",
        "text": "Participants between the ages of 35 and 65 are needed for this study. The purpose of the study is to fill in what we don’t know about how schizophrenia affects people as they get older. We want to find out what we can do to help older individuals with schizophrenia live better lives. The study includes 4 visits over the course of two weeks. The screening visit will take 2 hours. The first study visit will take 3 hours. The second study visit will take 2 hours. The third study visit will take 9 hours. This study will include: a clinical interview, cognitive batteries, questionnaires and assessments related to your daily and psychiatric functioning, two 90 minute MRI scans of your brain, a fasting blood draw, and a urine drug screen and pregnancy test (for females). Compensation is up to $310. TO SEE IF YOU QUALIFY PLEASE CONTACT (205) 934-8203.\n\nIf you experience urine leakage and you are 65 years or older, you may qualify for the study.\n\nWe are assessing whether hip exercises can improve pelvic floor muscle strength and urinary leakage.\n\nYou will serve as a “control.” At the visit, you will undergo a routine examination (10 minutes) for urinary leakage and answer questionnaires (10-15 minutes).\n\nYou will come to clinic for two visits.\n\n$100 ($50 at each visit) compensation will be provided.\n\nFor more information, please call 205.934.5498.\n\nA Phase 3, Randomized, Multicenter, Open-label Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared with Semaglutide Once Weekly in Adult Participants with Type 2 Diabetes and Inadequate Glycemic Control with Metformin with or without SGLT2 Inhibitor (TRANSCEND-T2D-2)\n\nTRANSCEND-T2D-2 is a clinical research study for people with type 2 diabetes.\n\nThis study will test if an investigational medicine (the medicine being studied) can\n\nhelp with blood glucose (sugar) and weight management compared with an existing\n\ntreatment for type 2 diabetes.\n\nAre aged 18 years or older\n\nHave type 2 diabetes\n\nHave been taking 1500mg or more of metformin each day for at least 3 months (with or without SGLT2i)\n\nHave a BMI of 25 or more\n\nHave HbA1c levels of 7.0% to 10.5%\n\nTo see if you qualify please contact at 205-996-4015, 205-934-5564 or via mail at tthoma@uab.edu or ccnrn@uab.edu\n\nWe are looking for people with knee osteoarthritis to participate in a study to examine whether a diet intervention can reduce pain and improve quality of life. The commitment to this study will last approximately 7 weeks and include the following:\n\nFive (5) visits to UAB where you will fill out questionnaires, complete a DEXA scan, blood draw or Quantitative Sensory testing. These visits will last anywhere from 1-3 hrs.\n\nSix (6) weeks on a randomized diet where we will provide three (3) meals and two to three (2-3) snacks per day.\n\nParticipants must:\n\nBe currently suffering from pain related to knee osteoarthritis\n\nBe free from other serious health conditions (diabetes, cardiovascular disease, eating disorders, metabolic disease)\n\nParticipants will receive up to $250 for completing the study and meals will be provided. Please contact DIRECT at DIRECTPAIN1@gmail.com (205) 834-3628. Leave a short message with your name and number.\n\nDAY or NIGHT, when is the best time to take your blood pressure medication?\n\nHelp us find out by joining our study at UAB by participating in the PRECISION-BP research study investigating the effects of Sacubitril/Valsartan or Valsartan on your body’s 24-hour rhythm of a hormone in your blood called natriuretic peptides. This hormone and the study medications are related to the heart. Eligible participants must be obese (BMI: 30-45 kg/m2) men and women, have high blood pressure, and have no history of heart or kidney problems. The study involves wearing a blood pressure monitor for 24 hours, 24-hour inpatient visits at UAB Hospital, taking medications, and collecting blood and urine samples. Meals will be provided at no cost. Participants will be compensated $575 for completing the study visits. Please e-mail Haley at PRECISION-BPSTUDY@uabmc.edu or call us at 205-975-5825 if you are interested.\n\nIf the answer to all of these questions is YES, you could be eligible to participate in a research study examining the impact of gender identity, hormone levels and sex assigned at birth to pain sensitivity in people who have chronic low back pain. – the ERASED study (Racial and Socioeconomic Differences in Chronic Low Back Pain).\n\nThe commitment to this study is two visits that will last approximately 4-5 hours and include:\n\nOne (1) telephone screen\n\nTwo (2) visits to UAB where you will fill out questionnaires, have a single blood draw, take part in pain sensitivity and functional testing.\n\nIf you are eligible to participate in this study, you will receive up to $400.\n\nParticipants must:\n\nIdentify as transgender\n\nBe between 18 and 85 years of age\n\nHave none of the following health conditions (HIV+, cardiovascular disease, uncontrolled hypertension)\n\nParticipants can be on HRT (hormone replacement therapy) or not.\n\nTo find out more about this study, call 205-934-8743. For information regarding research studies and rights of participants, call 205-834-3625.\n\nHelp us find out by joining our study at UAB by participating in the PRECISION-BP research study investigating the effects of Sacubitril/Valsartan or Valsartan on your body’s 24-hour rhythm of a hormone in your blood called natriuretic peptides. This hormone and the study medications are related to the heart. Eligible participants must be obese (BMI: 30-45 kg/m2) men and women, have high blood pressure, and have no history of heart or kidney problems. The study involves wearing a blood pressure monitor for 24 hours, 24-hour inpatient visits at UAB Hospital, taking medications, and collecting blood and urine samples. Meals will be provided at no cost. Participants will be compensated $575 for completing the study visits. Please e-mail Haley at PRECISION-BPSTUDY@uabmc.edu or call us at 205-975-5825 if you are interested.\n\nAre you between the ages of 11 and 19?\n\nAre you feeling sad, down, or hopeless?\n\nAre you feeling guilty, tense, or irritable?\n\nIf so, you may be eligible to participate in a study.\n\nCompensation provided.\n\nFor more information, please call Brennan Wink at 205-975-4208 or send an email to Brennanwink@uabmc.edu.\n\nHelp us find out by joining our study at UAB You may be eligible to participate in the PRECISION-BP research study investigating the effects of Sacubitril/Valsartan or Valsartan on your body’s 24-hour rhythm of a hormone in your blood called natriuretic peptides. This hormone and the study medications are related to the heart. Eligible participants must be obese (BMI: 30-45 kg/m2) men and women, have high blood pressure, and have no history of heart or kidney problems. The study involves wearing a blood pressure monitor for 24 hours, 24-hour inpatient visits at UAB hospital, taking medications, and collecting blood and urine samples. Meals will be provided at no cost. Participants will be compensated $575 for completing the study visits. Please e-mail Nehal at PRECISION-BPSTUDY@uabmc.edu or call us at 205-934-7173 if you are interested\n\nYou may be eligible to participate in a research study looking at the effects of sacubitril/valsartan on how your body handles insulin and glucose. This medication is related to blood pressure and is safe to take with or without hypertension. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart disease or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples. Participants will be compensated $675 for completing all the visits. To participate, please contact Haley at 205-975-5825 or email us at nauticalstudy@uabmc.edu.\n\nHelp us find out by joining our study. The University of Alabama at Birmingham, Department of Nutrition Sciences, is conducting an exciting research study, in collaboration with Pennington Biomedical Research Center, to investigate whether intermittent fasting or calorie restriction (i.e., losing weight) can improve health and slow the aging process.\n\nIf you are randomly selected to do calorie restriction, you may lose weight by eating less. If you are randomly selected to do intermittent fasting, you will fast for 16 hours per day and eat dinner by 6 pm about 6 days per week (1 break day per week). We want you to be successful: the study provides intensive coaching and support to help you successfully lose weight or practice intermittent fasting.\n\nTo qualify, you should:\n\nBe 25-45 years old\n\nHave a BMI between 22-30 Calculate your BMI here\n\nBe healthy\n\nNot currently taking any medications or supplements for chronic conditions\n\nNot smoke, vape, or use tobacco products currently or within the last 6 months\n\nNot currently participate in a regular program of heavy physical activity (e.g., jogging, running, or riding fast on a bicycle for 30 minutes or more per day)\n\nThe study involves collecting a medical history, body fat and bone scans, blood draws, urine collection, questionnaires, and other simple tests. Participation in the study will last approximately 7 months. Compensation of up to $1,500 is offered for the completion of this study. If you are interested in participating and think you may be eligible, please click the button below to screen online, call 205-934-1457, or email dial@uab.edu."
    }
}